We explain the science, not just the requirement.
Most regulatory consultants tell you what FDA needs. We tell you why, and what it means for your specific device, your data, and your timeline.
01
You will always know how your file will be read
We have reviewed submissions like yours from inside FDA. We know what a reviewer looks for first, where arguments typically break down, and how scientific gaps become deficiency letters. That knowledge is applied to your program from day one, so there are no surprises after you submit.
02
Every requirement comes with a rationale
We do not ask you to run a test or produce a document without explaining what scientific question it answers and why FDA expects it. You will understand the logic behind each element of your regulatory strategy, which means better decisions, fewer unnecessary studies, and a team that is genuinely prepared for the questions that follow.
03
Science-led, not process-led
Strong scientific rationale is not just good practice: it is the most practical tool a device company has. When the underlying science is sound and clearly reasoned, regulators ask fewer questions, additional information requests are avoided, and testing can be scoped to exactly what the submission requires. We help you identify which studies are genuinely necessary and build the scientific case that makes each one count.
04
Honest assessment at every stage
If your evidence has gaps, we identify them early and explain precisely what it would take to address them. Our value is in the accuracy of the assessment, not in telling you what you want to hear.
From early development to FDA response.
Stage 01
Early Strategy
Pathway, intended use, claims, classification, predicate landscape, and early evidence planning. Decisions made here shape everything downstream, so getting the pathway right early prevents costly rework later.
Stage 02
Pre-Testing
Protocol design, test selection, sample justification, CRO review, and standards alignment. This is where most budget gets wasted on the wrong tests, or the right tests at the wrong time, so getting the protocol right here protects your timeline and spend.
Stage 03
Submission
510(k), De Novo, PMA, Q-Sub, eSTAR, technical documentation, and scientific narrative. A submission is a technical argument, not a data dump, so how it is written determines whether a reviewer follows your reasoning the way you intend.
Stage 04
Post-Submission
Additional Information responses, deficiency remediation, FDA communication, and evidence gap closure. How you respond here determines whether the review closes out or drags into further cycles.